Topiramate
USP/1672206 - United States Pharmacopeia (USP) Reference Standard
Synonym: 2,3:4,5-
CAS Number: 97240-79-4
Empirical Formula (Hill Notation): C12H21NO8S
Molecular Weight: 339.36
MDL Number: MFCD00865320
Linear Formula: C12H21NO8S
Product Type: Chemical
API family | topiramate |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C12H21NO8S/c1-10(2)18- |
InChI key | KJADKKWYZYXHBB-XBWDGYHZSA |
manufacturer/tradename | USP |
SMILES string | NS(OC[C@]12[C@](OC(C)(C)O |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Topiramate USP Reference standard reference standard suitable for use in specified USP compendial quality tests and assays. Also used to prepare standard and system suitability solution during the assay, performance test, and impurity analysis by using liquid chromatography coupled with UV detectors in accordance with the given below monographs of United States Pharmacopeia (USP): • Topiramate • Topiramate Capsules • Topiramate Tablets • Topiramate Compounded Oral Suspension |
Biochem/physiol Actions: | Kainate GluR5 receptor antagonist; anticonvulsant. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |